Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis.
Explore this paper's citation graph
Summary
The effect of hemodialysis on components of the fibrinolytic system was measured in 22 patients and plasma levels of t- PA antigen, t-PA activity, u-PA antigen and plasminogen activator inhibitor were determined by means of immunological and functional assays.
- Type
- article
- Published
- 1987-08-01
- Cited by
- 43
- References
- 26
- Access
- Open access
- OpenAlex
- https://openalex.org/W1984798798
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:37519786
Keywords
Hemodialysis, Fibrinolysis, Tissue plasminogen activator, Plasminogen activator, Antigen
References
- Purification and characterization of human vascular plasminogen activator derived from blood vessel perfusates.
- Dialysis hypoxemia. Role of dialyzer membrane and dialysate delivery system.
- Characterization of a specific anti-human urokinase antibody: development of a sensitive competition radioimmunoassay for urokinase antigen.
- Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis.
- Induction of Fibrinolysis By Venous Obstruction
- Hemodialysis-associated platelet activation and thrombocytopenia.
- Plasminogen activator response after DDAVP: a clinico-pharmacological study.
- Some observations on the release of extrinsic and intrinsic plasminogen activators during exercise in man.
- Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system.
- Urokinase antigen in plasma: age and sex dependent variations.
- DEMONSTRATION OF UROKINASE‐RELATED FIBRINOLYTIC ACTIVITY IN HUMAN PLASMA
- Adrenergic Mechanisms in the Systemic Plasminogen Activator Response to Adrenaline in Man
- Sandwich ELISA for t-PA antigen employing a monoclonal antibody.
- Plasminogen: Purification from Human Plasma by Affinity Chromatography
- Studies on the Profibrinolytic Actions of Heparin and Its Fractions
- Studies of contact activation of blood in haemodialysis
- Effect of moderate exercise on the fibrinolytic system in normal young men and women.
- Release of plasminogen activator by acetylcholine from the isolated perfused pig ear.
- Complement activation and hypersensitivity reactions to dialysis membranes.
- Release of granulocyte proteinases during hemodialysis.
Cited by
- Uremic platelet dysfunction: past and present.
- Reduction in pO2 decreases the fibrinolytic potential of cultured bovine endothelial cells derived from pulmonary arteries and lung microvasculature.
- Dialysis modality and the risk of allograft thrombosis in adult renal transplant recipients.
- Evidence for the role of dialysis hypoxemia in the pathogenesis of hemodialysis-induced rise in tissue-type plasminogen activator.
- Role of bioincompatibility in dialysis morbidity and mortality.
- Increased blood fibrinolytic activity after physical exercise: comparative study in individuals with different sporting activities and in patients after myocardial infarction taking part in a rehabilitation sports program.
- Platelet function in uraemia.
- Enhanced blood coagulation and enhanced fibrinolysis during hemodialysis with prostacyclin.
- Plasma von Willebrand factor and thrombomodulin as markers of vascular disorders in patients undergoing regular hemodialysis therapy.
- Percutaneous liver biopsy complications in patients with chronic renal failure.
- Heparin induced increase of t-PA antigen plasma levels in patients with unstable angina: no evidence for clinical benefit of heparinization during the initial phase of treatment.
- Factor VII hyperactivity in chronic dialysis patients.
- Uremic levels of oxalic acid suppress replication and migration of human endothelial cells.
- The Role of Intrinsic Fibrinolytic System Activation in Pathogenesis of Hemostasis Disturbances in Hemodialized Patients with Chronic Renal Failure
- The Influence of the Haemodialysis Procedure on Platelets, Coagulation and Fibrinolysis
- Biocompatibility issues in hemodialysis.
- Impact of decreased renal function on coagulation and fibrinolysis in patients with non-valvular atrial fibrillation.
- Treatment of Bleeding in Dialysis Patients
- Plasminogen activator inhibitor-1 activity in chronic renal disease and dialysis.
- Thrombosis in End‐Stage Renal Disease
Related papers
- Depression of Tissue Plasminogen Activator (t-PA) Activity and Rise of t-PA Inhibition and Acute Phase Reactants in Blood of Patients with Acute Myocardial Infarction (AMI)
- Correlations between fibrinolytic function and acute myocardial infarction.
- Activities of wild‐type and variant tissue‐type plasminogen activators retained on vascular endothelial cells
- Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.
- Tissue plasminogen activator, plasminogen activator inhibitor-1, and fibrin as indexes of clinical course in cardiac allograft recipients. An immunocytochemical study.
- Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balance
- Recombinant lys-plasminogen given before, but not after, recombinant tissue-type plasminogen activator markedly improves coronary thrombolysis in dogs: relationship of thrombolytic efficacy with parameters of fibrinolysis.